Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 3
2001 9
2002 13
2003 14
2004 10
2005 10
2006 10
2007 4
2008 4
2009 12
2010 7
2011 8
2012 18
2013 19
2014 17
2015 20
2016 18
2017 12
2018 6
2019 10
2020 4
2021 9
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

203 results
Results by year
Filters applied: . Clear all
Page 1
Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.
Bandelow B, Baldwin D, Abelli M, Bolea-Alamanac B, Bourin M, Chamberlain SR, Cinosi E, Davies S, Domschke K, Fineberg N, Grünblatt E, Jarema M, Kim YK, Maron E, Masdrakis V, Mikova O, Nutt D, Pallanti S, Pini S, Ströhle A, Thibaut F, Vaghi MM, Won E, Wedekind D, Wichniak A, Woolley J, Zwanzger P, Riederer P. Bandelow B, et al. Among authors: zwanzger p. World J Biol Psychiatry. 2017 Apr;18(3):162-214. doi: 10.1080/15622975.2016.1190867. Epub 2016 Jul 15. World J Biol Psychiatry. 2017. PMID: 27419272 Free PMC article. Review.
[Pharmacotherapy of Anxiety Disorders].
Zwanzger P. Zwanzger P. Fortschr Neurol Psychiatr. 2016 May;84(5):306-14. doi: 10.1055/s-0042-106764. Epub 2016 Jun 14. Fortschr Neurol Psychiatr. 2016. PMID: 27299791 Review. German.
A response to the commentary "The role of mineralocorticoid receptor dysregulation in the neurocognitive impairment of patients recovered from depression" by Preston, S., Watson, S. and Gallagher, P. on "Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression" by Behnken, A., Bellingrath, S., Symanczik, J. P., Rieck, M. J., Zavorotnyy, M., Domschke, K., Arolt, V., & Zwanzger, P. doi: 10.1016/j.psyneuen.2012.07.005.
Bellingrath S, Behnken A, Arolt V, Zwanzger P. Bellingrath S, et al. Among authors: zwanzger p. Psychoneuroendocrinology. 2013 Mar;38(3):461-2. doi: 10.1016/j.psyneuen.2012.11.012. Epub 2012 Dec 11. Psychoneuroendocrinology. 2013. PMID: 23237814 No abstract available.
[Treatment of anxiety disorders].
Zwanzger P. Zwanzger P. MMW Fortschr Med. 2018 Oct;160(17):48-54. doi: 10.1007/s15006-018-0025-z. MMW Fortschr Med. 2018. PMID: 30302717 Review. German. No abstract available.
Pharmacological treatment of panic disorder.
Bandelow B, Baldwin DS, Zwanzger P. Bandelow B, et al. Among authors: zwanzger p. Mod Trends Pharmacopsychiatry. 2013;29:128-43. doi: 10.1159/000351953. Epub 2013 Sep 20. Mod Trends Pharmacopsychiatry. 2013. PMID: 25225023 Review.
"Torpedo" for the brain: perspectives in neurostimulation.
Zwanzger P, Herrmann MJ, Baeken Ch. Zwanzger P, et al. J Neural Transm (Vienna). 2016 Oct;123(10):1119-20. doi: 10.1007/s00702-016-1613-7. J Neural Transm (Vienna). 2016. PMID: 27638712 No abstract available.
203 results